Global Rheumatoid Arthritis (RA) Drugs Market Research Report 2023

Global Rheumatoid Arthritis (RA) Drugs Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 NSAIDs
1.2.3 Analgesic Drugs
1.2.4 Corticosteroids
1.2.5 DMARDs
1.2.6 Biological Therapies
1.2.7 JAK-inhibitors
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis (RA) Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rheumatoid Arthritis (RA) Drugs Market Perspective (2018-2029)
2.2 Rheumatoid Arthritis (RA) Drugs Growth Trends by Region
2.2.1 Global Rheumatoid Arthritis (RA) Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Rheumatoid Arthritis (RA) Drugs Historic Market Size by Region (2018-2023)
2.2.3 Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Region (2024-2029)
2.3 Rheumatoid Arthritis (RA) Drugs Market Dynamics
2.3.1 Rheumatoid Arthritis (RA) Drugs Industry Trends
2.3.2 Rheumatoid Arthritis (RA) Drugs Market Drivers
2.3.3 Rheumatoid Arthritis (RA) Drugs Market Challenges
2.3.4 Rheumatoid Arthritis (RA) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatoid Arthritis (RA) Drugs Players by Revenue
3.1.1 Global Top Rheumatoid Arthritis (RA) Drugs Players by Revenue (2018-2023)
3.1.2 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Rheumatoid Arthritis (RA) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rheumatoid Arthritis (RA) Drugs Revenue
3.4 Global Rheumatoid Arthritis (RA) Drugs Market Concentration Ratio
3.4.1 Global Rheumatoid Arthritis (RA) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis (RA) Drugs Revenue in 2022
3.5 Rheumatoid Arthritis (RA) Drugs Key Players Head office and Area Served
3.6 Key Players Rheumatoid Arthritis (RA) Drugs Product Solution and Service
3.7 Date of Enter into Rheumatoid Arthritis (RA) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatoid Arthritis (RA) Drugs Breakdown Data by Type
4.1 Global Rheumatoid Arthritis (RA) Drugs Historic Market Size by Type (2018-2023)
4.2 Global Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Type (2024-2029)
5 Rheumatoid Arthritis (RA) Drugs Breakdown Data by Application
5.1 Global Rheumatoid Arthritis (RA) Drugs Historic Market Size by Application (2018-2023)
5.2 Global Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Rheumatoid Arthritis (RA) Drugs Market Size (2018-2029)
6.2 North America Rheumatoid Arthritis (RA) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2018-2023)
6.4 North America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis (RA) Drugs Market Size (2018-2029)
7.2 Europe Rheumatoid Arthritis (RA) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country (2018-2023)
7.4 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size (2018-2029)
8.2 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rheumatoid Arthritis (RA) Drugs Market Size (2018-2029)
9.2 Latin America Rheumatoid Arthritis (RA) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2018-2023)
9.4 Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size (2018-2029)
10.2 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Introduction
11.1.4 AbbVie Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Rheumatoid Arthritis (RA) Drugs Introduction
11.2.4 Roche Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Rheumatoid Arthritis (RA) Drugs Introduction
11.3.4 Merck Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.3.5 Merck Recent Development
11.4 HEYL Chemisch-pharmazeutische Fabrik
11.4.1 HEYL Chemisch-pharmazeutische Fabrik Company Detail
11.4.2 HEYL Chemisch-pharmazeutische Fabrik Business Overview
11.4.3 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Introduction
11.4.4 HEYL Chemisch-pharmazeutische Fabrik Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.4.5 HEYL Chemisch-pharmazeutische Fabrik Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Amgen, Inc.
11.6.1 Amgen, Inc. Company Detail
11.6.2 Amgen, Inc. Business Overview
11.6.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Introduction
11.6.4 Amgen, Inc. Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.6.5 Amgen, Inc. Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Rheumatoid Arthritis (RA) Drugs Introduction
11.7.4 Pfizer Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Introduction
11.8.4 Bristol-Myers Squibb Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 UCB
11.9.1 UCB Company Detail
11.9.2 UCB Business Overview
11.9.3 UCB Rheumatoid Arthritis (RA) Drugs Introduction
11.9.4 UCB Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.9.5 UCB Recent Development
11.10 GSK
11.10.1 GSK Company Detail
11.10.2 GSK Business Overview
11.10.3 GSK Rheumatoid Arthritis (RA) Drugs Introduction
11.10.4 GSK Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.10.5 GSK Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Rheumatoid Arthritis (RA) Drugs Introduction
11.11.4 Sanofi Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.11.5 Sanofi Recent Development
11.12 Abbott Laboratories
11.12.1 Abbott Laboratories Company Detail
11.12.2 Abbott Laboratories Business Overview
11.12.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Introduction
11.12.4 Abbott Laboratories Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.12.5 Abbott Laboratories Recent Development
11.13 Teva Pharmaceutical
11.13.1 Teva Pharmaceutical Company Detail
11.13.2 Teva Pharmaceutical Business Overview
11.13.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Introduction
11.13.4 Teva Pharmaceutical Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
11.13.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of NSAIDs
Table 3. Key Players of Analgesic Drugs
Table 4. Key Players of Corticosteroids
Table 5. Key Players of DMARDs
Table 6. Key Players of Biological Therapies
Table 7. Key Players of JAK-inhibitors
Table 8. Global Rheumatoid Arthritis (RA) Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Rheumatoid Arthritis (RA) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Rheumatoid Arthritis (RA) Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Rheumatoid Arthritis (RA) Drugs Market Share by Region (2018-2023)
Table 12. Global Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Rheumatoid Arthritis (RA) Drugs Market Share by Region (2024-2029)
Table 14. Rheumatoid Arthritis (RA) Drugs Market Trends
Table 15. Rheumatoid Arthritis (RA) Drugs Market Drivers
Table 16. Rheumatoid Arthritis (RA) Drugs Market Challenges
Table 17. Rheumatoid Arthritis (RA) Drugs Market Restraints
Table 18. Global Rheumatoid Arthritis (RA) Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Rheumatoid Arthritis (RA) Drugs Market Share by Players (2018-2023)
Table 20. Global Top Rheumatoid Arthritis (RA) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis (RA) Drugs as of 2022)
Table 21. Ranking of Global Top Rheumatoid Arthritis (RA) Drugs Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Rheumatoid Arthritis (RA) Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Rheumatoid Arthritis (RA) Drugs Product Solution and Service
Table 25. Date of Enter into Rheumatoid Arthritis (RA) Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rheumatoid Arthritis (RA) Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Type (2018-2023)
Table 29. Global Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Type (2024-2029)
Table 31. Global Rheumatoid Arthritis (RA) Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application (2018-2023)
Table 33. Global Rheumatoid Arthritis (RA) Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application (2024-2029)
Table 35. North America Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Rheumatoid Arthritis (RA) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 50. AbbVie Company Detail
Table 51. AbbVie Business Overview
Table 52. AbbVie Rheumatoid Arthritis (RA) Drugs Product
Table 53. AbbVie Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 54. AbbVie Recent Development
Table 55. Roche Company Detail
Table 56. Roche Business Overview
Table 57. Roche Rheumatoid Arthritis (RA) Drugs Product
Table 58. Roche Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 59. Roche Recent Development
Table 60. Merck Company Detail
Table 61. Merck Business Overview
Table 62. Merck Rheumatoid Arthritis (RA) Drugs Product
Table 63. Merck Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 64. Merck Recent Development
Table 65. HEYL Chemisch-pharmazeutische Fabrik Company Detail
Table 66. HEYL Chemisch-pharmazeutische Fabrik Business Overview
Table 67. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Product
Table 68. HEYL Chemisch-pharmazeutische Fabrik Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 69. HEYL Chemisch-pharmazeutische Fabrik Recent Development
Table 70. Johnson & Johnson Company Detail
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product
Table 73. Johnson & Johnson Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 74. Johnson & Johnson Recent Development
Table 75. Amgen, Inc. Company Detail
Table 76. Amgen, Inc. Business Overview
Table 77. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product
Table 78. Amgen, Inc. Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 79. Amgen, Inc. Recent Development
Table 80. Pfizer Company Detail
Table 81. Pfizer Business Overview
Table 82. Pfizer Rheumatoid Arthritis (RA) Drugs Product
Table 83. Pfizer Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Bristol-Myers Squibb Company Detail
Table 86. Bristol-Myers Squibb Business Overview
Table 87. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product
Table 88. Bristol-Myers Squibb Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 89. Bristol-Myers Squibb Recent Development
Table 90. UCB Company Detail
Table 91. UCB Business Overview
Table 92. UCB Rheumatoid Arthritis (RA) Drugs Product
Table 93. UCB Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 94. UCB Recent Development
Table 95. GSK Company Detail
Table 96. GSK Business Overview
Table 97. GSK Rheumatoid Arthritis (RA) Drugs Product
Table 98. GSK Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 99. GSK Recent Development
Table 100. Sanofi Company Detail
Table 101. Sanofi Business Overview
Table 102. Sanofi Rheumatoid Arthritis (RA) Drugs Product
Table 103. Sanofi Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 104. Sanofi Recent Development
Table 105. Abbott Laboratories Company Detail
Table 106. Abbott Laboratories Business Overview
Table 107. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product
Table 108. Abbott Laboratories Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 109. Abbott Laboratories Recent Development
Table 110. Teva Pharmaceutical Company Detail
Table 111. Teva Pharmaceutical Business Overview
Table 112. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product
Table 113. Teva Pharmaceutical Revenue in Rheumatoid Arthritis (RA) Drugs Business (2018-2023) & (US$ Million)
Table 114. Teva Pharmaceutical Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatoid Arthritis (RA) Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Rheumatoid Arthritis (RA) Drugs Market Share by Type: 2022 VS 2029
Figure 3. NSAIDs Features
Figure 4. Analgesic Drugs Features
Figure 5. Corticosteroids Features
Figure 6. DMARDs Features
Figure 7. Biological Therapies Features
Figure 8. JAK-inhibitors Features
Figure 9. Global Rheumatoid Arthritis (RA) Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Rheumatoid Arthritis (RA) Drugs Market Share by Application: 2022 VS 2029
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Rheumatoid Arthritis (RA) Drugs Report Years Considered
Figure 15. Global Rheumatoid Arthritis (RA) Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Rheumatoid Arthritis (RA) Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Rheumatoid Arthritis (RA) Drugs Market Share by Region: 2022 VS 2029
Figure 18. Global Rheumatoid Arthritis (RA) Drugs Market Share by Players in 2022
Figure 19. Global Top Rheumatoid Arthritis (RA) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis (RA) Drugs as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Rheumatoid Arthritis (RA) Drugs Revenue in 2022
Figure 21. North America Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Rheumatoid Arthritis (RA) Drugs Market Share by Country (2018-2029)
Figure 23. United States Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Rheumatoid Arthritis (RA) Drugs Market Share by Country (2018-2029)
Figure 27. Germany Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Share by Region (2018-2029)
Figure 35. China Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Rheumatoid Arthritis (RA) Drugs Market Share by Country (2018-2029)
Figure 43. Mexico Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Share by Country (2018-2029)
Figure 47. Turkey Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. AbbVie Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 50. Roche Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 52. HEYL Chemisch-pharmazeutische Fabrik Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 54. Amgen, Inc. Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 55. Pfizer Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 57. UCB Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 58. GSK Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 59. Sanofi Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 60. Abbott Laboratories Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 61. Teva Pharmaceutical Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs